Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Yes, 3x ETFs are Awesome!
Like TNA, UGAZ, UWTI, NUGT? We do too...Join Up!
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | -0.37% | 86.27 | 1.3% | $1274.24m | |
| AMGN | Amgen Inc. | 0.97% | 203.88 | 1.2% | $676.03m | |
| GILD | Gilead Sciences, Inc. | 0.77% | 69.18 | 0.9% | $577.80m | |
| LOXO | Loxo Oncology Inc | 0.11% | 233.50 | 12.7% | $474.39m | |
| BIIB | Biogen Inc. | -0.27% | 337.42 | 1.3% | $459.87m | |
| ILMN | Illumina, Inc. | 0.87% | 312.75 | 3.5% | $351.51m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 2.19% | 194.70 | 1.9% | $332.94m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.35% | 418.84 | 2.6% | $322.26m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 2.12% | 117.05 | 2.0% | $239.80m | |
| TSRO | TESARO, Inc. | 0.03% | 74.96 | 14.4% | $196.22m | |
| A | Agilent Technologies, Inc. | 2.10% | 72.31 | 1.5% | $166.45m | |
| EXAS | Exact Sciences Corporation | 4.19% | 78.80 | 25.3% | $156.07m | |
| INCY | Incyte Corporation | -0.32% | 78.42 | 2.5% | $153.20m | |
| SRPT | Sarepta Therapeutics, Inc. | 1.22% | 122.80 | 15.4% | $142.40m | |
| LGND | Ligand Pharmaceuticals Incorporated | 6.49% | 117.90 | 23.1% | $123.00m |
Company Profile
Blueprint Medicines Corp. engages in the research, development, and commercialization of pharmaceutical products. It focuses on medicines to improve the lives of patients with genomically defined cancers and rare diseases. Its portfolio includes BLU-285 and BLU-554 for the treatment of gastrointestinal stromal tumors, systemic mastocytosis, and leukemia. The company was founded by Chris Varma, Nicholas B. Lydon, Brian Druker, and Alexis Borisy in October 2008 and is headquartered in Cambridge, MA.